Improving the regulation of medical cannabis in Canada to better serve pediatric patients

Children with chronic debilitating illness and pain are increasingly using cannabis for medical purposes, particularly when conventional treatment options have limited benefit or substantial adverse effects. Caregivers are becoming aware of evidence that suggests medical cannabis provides benefit fo...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) 2021-10, Vol.193 (41), p.E1596-E1599
Main Authors: Huntsman, Richard J, Kelly, Lauren E, Alcorn, Jane, Appendino, Juan Pablo, Bélanger, Richard E, Crooks, Bruce, Finkelstein, Yaron, Gilpin, Andrea, Lewis, Evan, Litalien, Catherine, Jacobs, Julia, Moore-Hepburn, Charlotte, Oberlander, Timothy, Rassekh, S Rod, Repetski, Alexander E, Rieder, Michael J, Shackelford, Alan, Siden, Hal, Szafron, Michael, 't Jong, Geert W, Vaillancourt, Régis
Format: Article
Language:English
Subjects:
Brochures
Canada
Cannabidiol
Cannabinoids - therapeutic use
Caregivers
Certification
Child
Children
Children & youth
Chronic diseases
Clinical trials
Consortia
Diseases
Drug dosages
Drug therapy
Good Manufacturing Practice
Government Regulation
Health care industry
Health Policy
Humans
Labeling
Laws, regulations and rules
Legalization of narcotics
Licenses
Medical marijuana
Medical Marijuana - therapeutic use
Patients
Pediatrics
Pharmaceutical industry
Practice Guidelines as Topic
Regulation
Research funding
Surveillance
Tetrahydrocannabinol
THC
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Children with chronic debilitating illness and pain are increasingly using cannabis for medical purposes, particularly when conventional treatment options have limited benefit or substantial adverse effects. Caregivers are becoming aware of evidence that suggests medical cannabis provides benefit for children with conditions that include drug-resistant epilepsy, cancer pain and autism. At present, children and youth aged 18 years and younger access medical cannabis through a framework regulated by Health Canada. Here, Huntsman et al argue that improvements in medical cannabis regulation are needed to better serve pediatric patients.
ISSN:0820-3946
1488-2329
DOI:10.1503/cmaj.202169